In this study, we developed a new method for simultaneous determination of verapamil hydrochloride (VerHCl) and its metabolite norverapamil hydrochloride (NorHCl) by using the capillary electrophoresis-electrochemiluminescence. Under optimized experimental conditions, the linear ranges of the VerHCl and NorHCl concentrations were 0.015-10.0 and 0.060-10.0μg/mL, respectively. The linearity relations were determined using the respective regression equations y=581.2x+19.94 and y=339.4x+29.16. The respective limits of detection (S/N=3) were 0.006 and 0.024μg/mL. The proposed method was used to study the pharmacokinetics of both agents in rat plasma. The maximum concentration (Cmax), half-life time (T1/2) and time to peak (Tmax) were 683.21±74.81ng/mL, 0.52±0.21h and 2.49±0.32h for VerHCl and 698.42±71.45ng/mL, 1.14±0.26h and 2.83±0.23h for NorHCl, respectively, following oral administration of 10mg/kg VerHCl.